Download reimbursement issues

Document related concepts

HIV trial in Libya wikipedia , lookup

Viral phylodynamics wikipedia , lookup

Pandemic wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Harm reduction wikipedia , lookup

Infection wikipedia , lookup

Infection control wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Epidemiology of HIV/AIDS wikipedia , lookup

Syndemic wikipedia , lookup

Diseases of poverty wikipedia , lookup

HIV and pregnancy wikipedia , lookup

Index of HIV/AIDS-related articles wikipedia , lookup

Transcript
Chapter 16
Care of the Patient with HIV/AIDS
Mosby items and derived items © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Nursing and the History of
HIV

1979- physicians in New York and California
were noting cases of Pneumocystis jiroveci
pneumonia (PCP) and Kaposi’s sarcoma (KS).

PCP-an unusual pulmonary disease caused by
fungus and primarily associated with people
who have suppressed immune systems.

Kaposi’s-rare cancer of the skin and mucous
membranes characterized by red, blue, purple
raised lesions

These two diseases were occurring at
alarming rates in homosexual men whose
immune systems were failing.
Nursing and the History of
HIV

June 1981 – CDC reported a HIV
epidemic including hemopheliacs,
drug users, heterosexual and
homosexual patients

The cases of HIV infection and AIDS
increased rapidly through the 1980s
Nursing and the History of
HIV

In 1986 the virus was named the human
immunodeficiency virus (HIV), and two
viruses were identified:
 HIV-1(found
throughout the world
and responsible for the majority of
HIV infection cases) and
 HIV-2 (found primarily in West
Africa) less progressive onset
Nursing and History of HIV

1987- CDC reported three cases of
occupationally acquired HIV
infection in health care providers.
“Universal Blood and Body Fluid
Precautions” guidelines were then
developed for the prevention of
occupational exposure.
Copyright © 2013, 2009, 2005 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
Slide 5
Trends HIV infections
 Although
infection rates initially
declined from 1983-1996, they now
remain the same due to many feeling
HIV is a chronic/treatable disease and
increased high-risk behaviors.
 African-Americans are estimated to
have an incidence rate of new HIV
infections that is eight times higher
than that of Caucasians
 Women account for 25% of HIV
infections
HIV Timeline
Transmission of HIV

Transmission occurs through sexual
practice not preference

Worldwide sexual intercourse most
common mode of transmission but in US ½
new HIV cases related to injection use

Transmitted from human to human
 Blood
 Semen
 Cervicovaginal
 Breast
milk
secretions
Transmission of HIV

HIV is an obligate virus
 It
cannot survive very long outside of
the human body
 Transmitted
 Infected
 Vaginal
person-to-person through
blood
secretions
 Semen
 Breast
 Or
milk
body fluids containing blood
Transmission of HIV
 Other
body fluids contain HIV;
no evidence they are capable
of transmission
Saliva
Urine
Tears
Feces
3 Most Common Modes of
Transmission of HIV
Sexual transmission
 Anal or vaginal intercourse
 Parenteral exposure
 Contaminated drug injecting equipment
and paraphernalia
 Transfusion of blood and blood products
(rare)
 Perinatal (vertical) transmission
 Transmission from mother to child

 May
occur during pregnancy, delivery,
or postpartum breastfeeding
HIV Transmission

Once infected, individual is capable of
transmitting to others at any time throughout the
disease spectrum

Even when host appears healthy and symptom
free

Viral load (amount of HIV is blood) is highest
immediately after infection and during later
stages of disease

During these stages, unprotected exposure to
infected individual increases likelihood
transmission will occur

But can still occur during any time in the
disease spectrum
Sexual Transmission

Most common mode of transmission

Some individuals become infected after one
encounter

Others remain free from infection after hundreds
of encounters

Receptive anal intercourse most risky behavior


Rectum is tighter and less lubricated; may
become torn and provide portal for virus to
enter bloodstream
Other factors increasing risk

STI can increase risk of transmission through an
STI-related lesion
Sexual Transmission

Females have a greater risk for
becoming infected because the
vagina has a greater area of mucous
membranes than the penis

And there is a greater amount of
HIV found in semen compared with
vaginal secretions
Copyright © 2013, 2009, 2005 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
Slide
14
Parenteral Transmission

Injecting Drug Use

Exposure to injecting equipment and
paraphernalia

Not limited to illicit drug use; injectable
steroids, vitamins, and insulin

Additional factors include poor nutrition,
hygiene, impaired judgment,

Increased risk for Hep B and C, other blood
borne illnesses

Syringe exchange program availability for
persons unable to stop – new sterile syringes
and needles
Parental Transmission

Autologous (one’s own blood) blood
transfusion is the safest to prevent HIV
infection. .

There is a 1 in 1.8 million units chance of
HIV transmission from donated blood that
is infected but has not yet had time to
develop antibodies
Copyright © 2013, 2009, 2005 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
Slide
16
Occupational Exposure

Occupational HIV transmission is RARE

Most infections occur after needlestick
injury but risk of contracting HIV is low;
about 0.3%.

Postexposure to antiviral therapy given to
health care workers after documented
exposure can result in severe hepatitis
and liver transplant.
Perinatal Exposure

Transmission of infection from mother to
infant during pregnancy or through
breastmilk

30% infected mothers will transmit HIV to
their infants

Approximately 50%-70% of the
transmissions will occur late in utero or
intrapartum

Recommended testing during pregnancy
Question

The physician asks the nurse to talk with a patient
about how HIV is transmitted. Which route of
transmission should be discussed?

1. Receiving blood, donating blood

2. Food, water and air

3. Sexual intercourse, sharing needles, mother-tochild transmission

4. Dirty toilets, swimming pools, mosquitoes
Answer


3. Sexual intercourse, sharing needles and motherto-child transmission
Transmission of HIV
Pathophysiology

Normal immune response
 Foreign
B
antigens interact with B cells
cells initiate antibody development
B
cells and T cells initiate cellular
immune response
B
cells reduce virus in blood
T
cells reduce virus in lymph nodes
Pathophysiology

Infection with HIV causes destruction of
immune cells
 “Slow”
(long time passes before s/s
appear) retrovirus (only has ribonucleic
acid – RNA for genetic material)
 T-cells
or CD4+ lymphocytes are the
primary targets for HIV infection
 Because
CD4 and T lymphocytes
orchestrate all immune functions,
HIV’s attack on these cells result in
progressive impairment of the body’s
immune response
Spectrum of HIV
 Initial
exposure
 Primary
HIV infection
 Flu-like
symptoms
 Develop
antibodies to HIV 3 – 6
months after infection
 HIV
seropositivity (seroconversion)
 Positive
 95%
HIV antibody test
within 3 months; 99% within
6 months
HIV
Spectrum of HIV
 Early
HIV disease – Clinical latency
stage – Symptom-free period
 Signs
and symptoms may not appear
until
8 to 12 years after exposure
 The
virus remains in the lymph
nodes, liver and spleen and
reproduces
 One
in six persons do not know they
are infected with the virus
Spectrum of HIV

Early symptomatic disease

CD4+ cell count drops below 500 cells/mcL

Persistent, unexplained fevers

Drenching night sweats

Chronic diarrhea

Headaches

Fatigue

Lymphadenopathy (swollen lymph nodes)

Recurrent or localized infections

Neurological manifestations (memory
impairment, leg weakness, loss of balance)

THRUSH most common
Diagnostic Studies

HIV antibody testing
 ELISA
 Enzyme-linked
immunosorbent assay
 Detects
the presence of HIV
antibodies
 If
positive, ELISA is done a second
time
 Western
blot
 Done
if second ELISA is positive
 More
sensitive than ELISA
Diagnosis and Testing
Diagnostic Studies

CD4+ lymphocyte count
 Normally
600 to 1200 mcL
 Decreases
as the disease progresses
 Best
marker for the immunodeficiency
associated with HIV infection

Viral load monitoring
 Level
of virus in the blood
 Provides
significant information toward
predicting the course of the disease
Diagnostic Studies


Seropositive

All three tests are positive (ELISA  2 and
Western blot)

Does NOT mean the person has AIDS
Seronegative

Not an assurance that an individual is free
from HIV infection

Seroconversion may not have occurred yet
Figure 16-1
Viral load in the blood and the relationship to CD4 lymphocyte cell
count over the spectrum of HIV disease.
HIV viral load
Question

The purpose of doing a viral load study
every 3 to 4 months in the HIV positive
person is to determine:

1. the CD4 count

2. the progression of the disease

3. monitor immunosuppression levels

4. the results of the Western blot test
Answer

2. the progression of the disease

Viral load monitoring shows the level of
virus in the blood, provides significant
information toward predicting the course
of the disease
Spectrum of HIV Infection

AIDS
 The
end-stage, or terminal,
phase of the HIV infection

HIV positive and CD4+ (T4) count
below 200 or one or more AIDSindicator conditions
Therapeutic Management

Therapeutic management focus

Monitoring HIV disease progression and immune
function

Preventing the development of opportunistic
diseases

Initiating and monitoring antiretroviral therapy

Detecting and treating opportunistic diseases

Managing symptoms

Preventing complications of treatment
HIV management
Therapeutic Management

Pharmacological management

Most common opportunistic diseases associated with
HIV

Pneumocystis jiroveci (formerly carinii)
pneumonia (PCP)

Most common infection

Symptoms


Fever; night sweats; productive cough;
SOB
Treatment

Bactrim or Septra; pentamidine;
steroids

Wear gown, mask, and gloves during
patient care
Therapeutic Management

Pharmacological management (continued)
 Most common opportunistic diseases associated
with HIV (continued)
 Kaposi’s
sarcoma
 Most
common neoplasm found in HIVinfected patients
 Symptoms
 Reddish-purple
 Treatment
 Radiation
 Chemotherapy
spots on the skin
Therapeutic Management

Pharmacological management (continued)

Most common opportunistic diseases associated
with HIV (continued)
 Cytomegalovirus
(CMV)
 Symptoms
 Retinitis
 Colitis
 Treatment
 Ganciclovir
 Foscarnet
Therapeutic Management

Pharmacological management (continued)

Most common opportunistic diseases associated
with HIV (continued)
 Cryptococcal
meningitis
 Symptoms
 Fever
 Headache
 Treatment
 Amphotericin
 Fluconazole
B
Therapeutic Management

Pharmacological management (continued)
 Most common opportunistic diseases associated with
HIV (continued)

Toxoplasma encephalitis


Symptoms

Fever; headache; seizures

Mental changes
Treatment

Pyrimethamine and folic acid

Sulfadiazine

Clindamycin
Therapeutic Management

Pharmacological management (continued)

Most common opportunistic diseases associated with
HIV (continued)

Mycobacterium (avium complex and
tuberculosis)


Symptoms

Fever; chills; sweats

Abdominal pain; bone pain

Fatigue; diarrhea; nausea; weight loss
Treatment

Rifampin; INH; ciprofloxacin
Therapeutic Management

Pharmacological management (continued)
 Antiretroviral
therapy
 Combination
therapy prevents
development of resistance
 Must
be given around the clock
 Usually
initiated
 CD4+
 Viral
count below 350 mcL, or
load greater than 30,000
copies/mL
Therapeutic Management

Pharmacological management (continued)

Alternative and complementary therapies
 Massage
 Acupuncture
 Acupressure
 Biofeedback
 Nutritional
 Herbal
supplements
remedies
Nursing Interventions

Adherence
 Adhering
to a prescribed regimen is of
paramount importance to survival and
the success of treatment

Palliative care
 The
active, total care of patients
whose disease is not responsive to
curative treatment
Nursing Interventions

Psychosocial issues
 Uncertainty
 Isolation
 Fear
 Depression
 Limited
financial resources
Nursing Interventions

Assisting with coping
 Educate
about HIV
 Encourage
patients to participate in
their own care
 Encourage
patients to face life a day
at a time; live each day to the fullest
 Listen
 Maintain
support
sources of psychological
Nursing Interventions

Reducing anxiety

Clarification and education about HIV and AIDS

Include patient and support person in planning
care

Encourage talking about feelings or relaxation
and meditation

Assess for suicidal ideation

Support groups
Nursing Interventions

Minimize social isolation
 Social
stigma
Associated
with homosexuality, drug use,
and sexual transmission
 Sharing
Need
 Support
diagnosis with others
to choose carefully
groups
Patients
Significant
others
Nursing Interventions

Assisting with grieving
 Listening
 Explore
feelings, fears, and
treatment options
 Significant
others and family
members
May
experience fear, anger,
embarrassment, and shame
Nursing Interventions

Confidentiality
 Diagnosis
should be carefully protected
 Need-to-know
basis
 Not
every health care worker
needs to know diagnosis
 Universal
precautions should be
used with every patient
Nursing Interventions

Duty to treat
 Health
care professionals may not pick
and choose their patients

Ethical and legal principles
 Rehabilitation
Act of 1973 prohibits
discrimination against the handicapped
and the disabled
 HIV
and AIDS are included
Nursing Interventions
 Good
nutritional habits
 Elimination
of smoking and drug use
 Elimination
or moderation of
alcohol intake
 Regular
 Stress
exercise
reduction
 Avoidance
of exposure to new
infectious agents
 Mental
health counseling
 Involvement
 Safer
in support groups
sexual practices
Nursing Interventions

Later interventions
 Treat opportunistic diseases
 Diarrhea is often a long-term problem
 Low-fat,
low-fiber, high-potassium
diet
 Adequate
fluid intake
 Good
skin care
 Nutritional
 Encourage
 Increase
 Enteral
 TPN
nutritional supplements
protein
supplements (NG tube)
Prevention of HIV Infection

Education
 Best
means of prevention
 Counsel
about HIV testing, behaviors
that put people at risk, and how to
reduce or eliminate those risks
 Nurse
must be able to discuss
behaviors
 Forthright,
relaxed, and
nonjudgmental
Prevention of HIV Infection

HIV testing and counseling
 Pre-
and posttest counseling must be
done
 Patient
should not be pressured to be
tested
 Informed
consent must be obtained
before drawing blood
 Consent
laws are established by
state laws
 Confidential
or anonymous testing
Prevention of HIV Infection

Barriers to prevention
 Denial
 “It
won’t happen to me”
 Ignoring risks
 Fear, misunderstanding, and potential for
social isolation
 Cultural
and community attitudes, values,
and norms
 Opposed
schools
to HIV and AIDS education in
Prevention of HIV Infection

Decreasing risks related to drug use
 Stop
the use of injectable drugs
 Provide
 If
drug treatment opportunities
drugs are going to be injected
 Use
sterile needles and equipment
 Instructions
equipment
on cleaning needles and
Prevention of HIV Infection

Decreasing risks of occupational exposure
 Risk
is very low
 Handwashing
is the single most
effective means of preventing the
spread of infection
 Universal
Precautions and body
substance isolation
 High-risk
exposure treatment
 Begin
antiretroviral medications
within 1 to 4 hours for at least 4
weeks
 HIV
testing: Baseline, 6 months, and
12 months
Prevention of HIV Infection

Other methods to reduce risk

HIV-infected person should be given the
following instructions:
 Do
not give blood, donate organs, or
donate semen
 Do
not share razors, toothbrushes, or other
household items that may contain blood or
other body fluids; shower instead of tub
bath
 Avoid
infecting sexual and needle-sharing
partners
 Do
not breastfeed
Chapter 13
Antivirals, Antiretrovirals, and Antifungal Medications
Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.
63
Antiretrovirals
Action
 Interfere with the ability of a retrovirus to
reproduce or replicate
 Two types:

Reverse transcriptase inhibitors
• Act early in viral life cycle
 Protease inhibitors
• Act later in viral life cycle
Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.
64
Antiretrovirals (cont.)
Uses
 Slow advance of AIDS
 Maintain immunity
 Prevention of HIV in infants born to HIVinfected mothers
 Prevention of HIV in health care workers
exposed to HIV
Drug Interactions
Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.
65
Antiretrovirals (cont.)
Nursing Implications and Patient Teaching
 Adherence is essential
 Medications do not cure
 Report all drugs and supplements used,
including OTC and CAM
 Signs and symptoms of pancreatitis
 Signs and symptoms of peripheral neuropathy
Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.
66
Antiretrovirals (cont.)
Nursing Implications and Patient Teaching
(cont.)
 Routes of disease transmission
 Need for social and financial support
Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.
67
Williams' Basic Nutrition & Diet
Therapy
14th Edition
Chapter 23
Nutrition Support in Cancer and
HIV/AIDS
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
68
Lesson 23.2: Nutrition
Support in HIV/AIDS

Nutrition problems affect the nature of
the disease process and the medical
treatment methods in patients with
cancer or AIDS.

The progressive effects of the human
immunodeficiency virus (HIV), through its
three stages of white T-cell destruction,
have many nutrition implications and
often require aggressive medical nutrition
therapy.
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
69
Process of AIDS Development
(p. 485)

Evolution of human immunodeficiency virus




First case identified in 1959
By late 1970s and early 1980s had spread to
Europe and United States
Underlying infectious agent identified in 1983
Parasitic nature


Viruses contain only shreds of genetic material
They invade a host cell and use it to make copies
of itself
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
70
Transmission and Stages of
Disease Progression (p. 487)


Modes of transmission
Three distinct stages



Primary infection and extended latent period of
HIV incubation
HIV-related diseases
AIDS
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
71
CD4+ T-Lymphocyte Conditions
(p. 487)





Terminal stage of HIV infection: AIDS
Rapidly declining T-lymphocyte counts
Kaposi’s sarcoma
Protozoan parasites
Cytomegalovirus
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
72
Medical Management of Patient
with HIV/AIDS (p. 489)



Delay progression of the infection and improve the
immune system
Prevent opportunistic illnesses
Recognize the infection early
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
73
Drug Therapy (p. 489)



Effective drug therapy is difficult because of highly
evolved nature of virus
Several drugs approved by FDA
Highly active antiretroviral therapy is current primary
drug regimen
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
74
Medical Nutrition Therapy
(cont’d) (p. 493)

Intervention



No specific nutrient recommendations for patient
with HIV
Reduce or eliminate malnutrition
Correct nutrition problems identified in
assessment
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
75
Complications of HIV/AIDS


AIDS Wasting Syndrome – involuntary loss of
more than 10% baseline body weight and
chronic weakness/fever/diarrhea for more
than 30 days
HIV Neurocognitive Disorder – HIV
associated dementia – HIV infection in the
brain or other parts of the Central Nervous
System –memory impairment, loss of
balance, slower responses, hallucinations
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
76
Causes of Body Wasting (p. 494)




Inadequate food intake
Malabsorption of nutrients
Disordered metabolism
Lean tissue wasting
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
77
Nutrition Counseling, Education,
and Supportive Care (p. 495)

Should focus on:
Appropriate, adequate food intake – encourage
small meals
 Food behaviors
 Symptoms that may affect food intake
 Benefits and risks of supplemental nutrients
 Nutritional strategies for symptom management

Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
78
Counseling Principles (p. 495)




Motivation for dietary changes
Rationale for nutrition support
Provider-patient agreement on plan
Development of manageable steps for change
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
79
Personal Food Management
Skills (p. 495)


Identify community programs (e.g., Meals on Wheels)
Provide psychosocial support
Copyright © 2013 Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
80